Neoral vs Sandimmun: interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipients. The U. K. Neoral Study Group.
作者信息
Lodge J P, Pollard S G
机构信息
Department of Organ Transplantation, St James' University Hospital, Leeds, U.K.
出版信息
Transplant Proc. 1997 Feb-Mar;29(1-2):272-3. doi: 10.1016/s0041-1345(96)00089-9.
PMID:9122991
Abstract
摘要
相似文献
1
Neoral vs Sandimmun: interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipients. The U. K. Neoral Study Group.
Transplant Proc. 1997 Feb-Mar;29(1-2):272-3. doi: 10.1016/s0041-1345(96)00089-9.
2
Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
Transplant Proc. 1996 Aug;28(4):2187-8.
3
Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group.
Transplant Proc. 1997 Nov;29(7):2945-7. doi: 10.1016/s0041-1345(97)00739-2.
4
Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
Transplant Proc. 1996 Aug;28(4):2199-201.
5
Comparison of efficacy, safety, and tolerability of Neoral vs Sandimmun in de novo renal transplant patients over 24 months' treatment.
Transplant Proc. 1997 Feb-Mar;29(1-2):275-6. doi: 10.1016/s0041-1345(96)00091-7.
6
Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. Neoral Renal Study Group.
Transplantation. 1999 Nov 15;68(9):1325-31. doi: 10.1097/00007890-199911150-00018.
7
Neoral versus Sandimmun: clinical impact and modification of immunosuppressive therapy in cardiac transplantation.
Transplant Proc. 1998 Aug;30(5):1904-5. doi: 10.1016/s0041-1345(98)00476-x.
8
9
Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
Kidney Int. 1998 Sep;54(3):938-44. doi: 10.1046/j.1523-1755.1998.00042.x.
10
A one-year comparative study of Neoral vs Consupren in de novo renal transplant patients.
Transplant Proc. 1998 Nov;30(7):3533-4. doi: 10.1016/s0041-1345(98)01125-7.
引用本文的文献
1
Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.
Pharmacoeconomics. 1998 Dec;14(6):691-708. doi: 10.2165/00019053-199814060-00009.
Zotero 插件